My watch list
my.bionity.com  
Login  

352 Current news from the ressort manufacturing

rss

You can refine your search further. Select from the filter options on the left to narrow down your results.

image description
Biological processing of precious metal ores

BRAIN AG and CyPlus GmbH develop disruptive technologies

25-Jun-2018

The bioeconomy company BRAIN AG and CyPlus GmbH have announced the development of an initial range of market-relevant products for the global mining industry. This work has been carried out as part of a multi-year collaboration between the companies in the area of biological ore processing to ...

more

Sanofi and Recipharm announce transfer of Holmes Chapel Manufacturing site

19-Jun-2018

Recipharm and Sanofi announced today that they have signed an agreement to transfer the Holmes Chapel site from global healthcare leader, Sanofi, to leading pharmaceutical contract development and manufacturing organisation, Recipharm. “Holmes Chapel brings Recipharm an ideal opportunity to ...

more

Sartorius Stedim Biotech and Siemens Sign Long-Term Cooperation Agreement in the Area of Automation

Siemens becomes a preferred supplier for automation solutions

14-Jun-2018

The Siemens technology group andSartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry, have agreed on long-term cooperation in the area of automation. This agreement provides that Sartorius Stedim Biotech will preferably use Siemens automation ...

more

image description
Reaction calorimetry in microreactors

12-Jun-2018

At Achema 2018 the Fraunhofer Institute for Chemical Technology will demonstrate the latest gen-eration of continuous reaction calorimeters. These permit rapid screening of thermokinetic data, making kinetic constants and safety-relevant data available in the early stages of process ...

more

PlasmidFactory expands lab capacities

30-Apr-2018

PlasmidFactory GmbH & Co. KG announces that it has acquired new laboratory space for research and development as well as for the highly documented production of plasmid DNA, and has begun reconstructing and equipping the same. "New capabilities are the key to helping our customers move to ...

more

Sanofi to invest €350 million in Canadian vaccine facility

Toronto facility is one of the largest-ever investments by Sanofi in a single building

13-Apr-2018

Sanofi is investing €350 million (CAD $500 million) for the construction of a new state-of-the-art vaccine manufacturing facility at the Sanofi Pasteur Canadian headquarters in Toronto, Ontario. The investment bolsters the company’s Canadian operations and its commitment to advancing public ...

more

image description
Lonza opens world's largest cell and gene therapy facility

Manufacturing plant in Texas exeeds 25,000 square meters

10-Apr-2018

Lonza today is opening the world’s largest dedicated cell-and-gene-therapy facility, which was built in anticipation of the rising demand from developers of cell and gene therapies – the next era in medicine – and with the mission of enabling them to deliver these types of treatments to patients ...

more

New international partnership promises great potential for next-generation biopharmaceuticals

New virus-free insect cell line

16-Mar-2018

There are a multitude of challenges associated with the production of next-generation biopharmaceuticals and vaccines. The Austrian Centre of Industrial Biotechnology and the BOKU - University of Natural Resources and Life Sciences, Vienna together with the Boyce Thompson Institute (BTI) Ithaca, ...

more

Merck Invests Additional €40 Million to Enhance Manufacturing and Distribution in Asia

Investment supports growing demand for biopharmaceutical manufacturing

22-Feb-2018

Merck announced an additional investment of€40 million to build a robust manufacturing and distribution platform in Asia over a span of two years. This investment follows Merck’s November 2016 announcement of its €80 million Life Science investment in Nantong, China. “In biopharmaceutical ...

more

image description
Research Reactor supplying radioisotope for new cancer drug

12-Feb-2018

More than 15 years ago, scientists at the University of Missouri's Research Reactor (MURR®) identified promising properties of the radioisotope lutetium-177 (Lu-177), which can be used to treat cancer. It was recently announced that the U.S. Food and Drug Administration has approved a Lu-177 ...

more

Page 3 From 36
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE